Pfizer To Seek FDA Emergency Use Authorization For Vaccine ‘Within Days,’ Final Analysis Shows 95% Effective
'Historic eight-month journey'
Full Article
Pfizer To Seek FDA Emergency Use Authorization For Vaccine ‘Within Days,’ Final Analysis Shows 95% Effective
Daily Caller
0 shares
1 views
You might like
Related news coverage
Moderna Seeks OK For Emergency Approval For COVID Vaccine, Now What?
Newsy
Watch VideoThe need for a COVID vaccine is greater than ever before as cases surge and hospitals are overwhelmed in much of the..
-
US stocks end down to close a historic November rally
Proactive Investors
-
US stocks seeing red at mid-session; Dow Jones looks for best monthly gain since 1987
Proactive Investors
-
Moderna vaccine 100 per cent effective against severe COVID-19
Mid-Day
-
Moderna asking US, European regulators to greenlight COVID-19 vax
Mid-Day
Advertisement
More coverage
Moderna claims 94% efficacy for COVID-19 vaccine, will ask FDA for emergency use authorization today
TechCrunch
Drugmaker Moderna has completed its initial efficacy analysis of its COVID-19 vaccine from the drug’s Phase 3 clinical study, and..
-
Pfizer Says Vulnerable Groups To Get Vaccine First
Newsy
-
Pfizer demands "emergency" authorization from FDA for experimental Covid-19 vaccine
NaturalNews.com
-
Pfizer seeking emergency use of its COVID-19 vaccine in US
Mid-Day
-
US stocks close lower amid rising COVID-19 cases and economic-outlook fears
Proactive Investors